Zhao, Xiaobin <br/><br/>
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.  [electronic resource] 

 -  Blood  Oct 2007 
 - 2569-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-12-062927  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Neoplasm--immunology<br/>Antibody-Dependent Cell Cytotoxicity--immunology<br/>Antigens, CD--genetics<br/>Antigens, CD19--metabolism<br/>Antigens, Neoplasm--genetics<br/>Apoptosis<br/>Caspases--metabolism<br/>Enzyme Activation<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Mice<br/>Mice, SCID<br/>Tetraspanins<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays